Published in AIDS Weekly, October 6th, 1997
Patients on this study benefited from a more convenient once-a-day dose of ddI.
The ddI/d4T/indinavir combination decreased viral load to undetectable levels within one month of therapy and maintained viral suppression for at least six months.
"The triple combination of ddI, d4T, and indinavir is a potent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.